Jonathan C. Javitt's most recent trade in NRX Pharmaceuticals Inc was a trade of 125,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NRX Pharma Inc | Jonathan C. Javitt | Director, Chairman and Chief Scientist, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2025 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| NRX Pharma Inc | Jonathan C. Javitt | Director, Chairman and Chief Scientist, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 17 Dec 2024 | 40,000 | 84,634 | - | 1.2 | 46,800 | Common Stock |
| NRX Pharma Inc | Jonathan C. Javitt | Director, Chief Scientist, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.33 per share. | 23 Aug 2023 | 100,000 | 446,332 | - | 0.3 | 33,000 | Common Stock |
| NRX Pharma Inc | Jonathan C. Javitt | Director, Chief Scientist, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.32 per share. | 22 Aug 2023 | 200,000 | 346,332 | - | 0.3 | 64,400 | Common Stock |
| NRX Pharma Inc | Jonathan C. Javitt | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 300,000 | 14,468,329 | - | 0 | Common Stock, par value $0.001 per share | |
| NRX Pharma Inc | Jonathan C. Javitt | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 07 Dec 2022 | 400,000 | 12,899,997 | - | 1 | 400,000 | Common Stock, par value $0.001 per share |
| NRX Pharma Inc | Jonathan C. Javitt | Director, Chief Scientist, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.58 per share. | 01 Jun 2022 | 100,000 | 146,332 | - | 0.6 | 58,000 | Common Stock |
| NRX Pharma Inc | Jonathan C. Javitt | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 13,348,997 | 13,348,997 | - | - | Common Stock | |
| NRX Pharma Inc | Jonathan C. Javitt | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 1,422,000 | 1,422,000 | - | - | Common Stock | |
| NRX Pharma Inc | Jonathan C. Javitt | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 46,332 | 46,332 | - | - | Common Stock |